General Dermatology

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Karl Yen of Sanofi discussed the role of amlitelimab in AD following sustained results and a promising safety profile presented in data at AAD.

Novartis highlighted key findings at AAD and AAAAI, showcasing Cosentyx's flexible dosing for hidradenitis suppurativa and remibrutinib’s efficacy for chronic spontaneous urticaria.

By staying authentic and leveraging real patient experiences, Tomassian ensures his content remains valuable and trustworthy.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

EltaMD’s Derm Difference campaign honors dermatologists’ expertise in skin health, cancer prevention, and confidence-boosting care.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This week, we feature top articles from our sister publications on updates in surgical management, diabetes control, and more.

This review of the latest dermatologic studies includes insights into erectile dysfunction in dermatology and venereology, diet and psoriasis information on TikTok, and more.

Test your knowledge of key words and terms associated with dermatology meeting news from the previous week.

Gold highlighted the growing role of energy-based devices in acne treatment during his AAD session.

Explore the top headlines of the week including insights on the environmental impact of conferences, new clinical data, and the shift towards more natural-looking results.

Lio shared insights on minimizing pain in dermatologic procedures, highlighting practical techniques from his AAD 2025 presentations.

Expect exciting news in the treatment of port-wine birthmarks, Kristen Marie Kelly, MD, told AAD Annual Meeting attendees.

In case you missed it, this week we had news about the achievements of female dermatologists for Women’s History Month, Takeda’s initiative to improve clinical disparities in psoriasis research, previews of this week’s AAD Annual Meeting, and more.

Alexandra P. Charrow, MD, FAAD, shares insights on the link between dermatology and irritable bowel disease at the AAD Annual Meeting.

Read more on how to navigate all the opportunities at this year’s AAD meeting, which starts today in Orlando, Florida.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

At AAAAI/WAO 2025, Bernstein explored new findings on rilzabrutinib and dupilumab in CSU, highlighting treatment gaps and future therapies.

The novel formulation improved the appearance of dry and chapped lips after 28 days of use.

Dematology Times' Editor in Chief interviews Adelaide Hebert, MD, who will be honored at the AAD 2025 Legacy Celebration for her impact on pediatric dermatology.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Celebrate Women’s History Month 2025 with insights from leading female dermatologists and expert coverage from the AAD Annual Meeting in Orlando.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Phase 3 trial results presented at AAAAI/WAO 2025 highlight dupilumab's efficacy in reducing itch severity and urticaria activity in CSU patients.

“It's so exciting to see all these incredible female talents behind me. I want to give back and I want to help them climb on my shoulders and go higher,” Haws said.

Explore the top headlines of the week including insights from Terri Philips, MD, FAAP, innovations in wound healing, and more.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about Arcutis’ sNDA for roflumilast in pediatric AD, the current clinical and aesthetic applications of snail mucin, positive results from the CHE delgocitinib trial in China, and more.

This week, we feature top articles from our sister publications on recent clinical trials, practice management, and innovative technology.